Zentalis Pharmaceuticals, Inc. (ZNTL)
NasdaqGM - NasdaqGM 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 20.06 |
| 開市 | 19.90 |
| 買盤 | 18.95 x 2200 |
| 賣出價 | 20.81 x 1200 |
| 今日波幅 | 19.45 - 20.26 |
| 52 週波幅 | 15.55 - 31.46 |
| 成交量 | |
| 平均成交量 | 531,631 |
| 市值 | 1.402B |
| Beta 值 (5 年，每月) | 1.78 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -4.71 |
| 業績公佈日 | 2023年11月07日 - 2023年11月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 49.60 |
BenzingaZentalis Gears Up for Phase 3 Study of Azenosertib after Positive Phase 1b Outcomes
Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) announced data from the Phase 1b trial of azenosertib in combination with chemotherapy in patients with platinum-resistant ovarian cancer. Azenosertib was well tolerated in combination with multiple types of chemotherapy and demonstrated encouraging clinical activity, with noteworthy improvements in objective response rates (ORRs) and median progression-free survival (mPFS) in all patients, especially those with Cyclin E1+ tumors. 115 patients were enr
